KaydedilenlerDerginizi ekleyin

Dergiler / Turkish Journal of Medical Sciences / 2018 / Cilt: 48 - Sayı: 4

Relationship of serum HLA-B alleles and TNF-α with rheumatic heart disease

Bülent BOYACI
Serkan ÜNLÜ
Abdurrahman TUFAN
Azmi EYİOL
Çağrı YAYLA
Mustafa CEMRİ
Rıdvan YALÇIN
Sayfa
724–729
Yayın Tarihi
2022-11-05
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

There was nocorrelation between TNF-α levels and mitral valve area (P = 0.066).Conclusion: Our findings confirmed the association between HLA-B alleles and rheumatic heart disease.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Background/aim: Acute rheumatic fever and rheumatic heart disease are major causes of morbidity and mortality in developingcountries.
📊
Temel Bulgular & Veri:The aim of this study was toevaluate the relationship of serum HLA-B alleles and tumor necrosis factor alpha (TNF-α) with rheumatic heart disease.Materials and methods: A total of 50 consecutive patients with rheumatic heart disease and 50 controls were enrolled in the study.
💡
Sonuç & Katkı:There was nocorrelation between TNF-α levels and mitral valve area (P = 0.066).Conclusion: Our findings confirmed the association between HLA-B alleles and rheumatic heart disease.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Abstract

Background/aim: Acute rheumatic fever and rheumatic heart disease are major causes of morbidity and mortality in developingcountries. Genetic studies have determined that the immune response in rheumatic heart disease is genetically controlled and that thereis a close relationship between the gene of concern and the class II human leukocyte antigen (HLA) gene. The aim of this study was toevaluate the relationship of serum HLA-B alleles and tumor necrosis factor alpha (TNF-α) with rheumatic heart disease.Materials and methods: A total of 50 consecutive patients with rheumatic heart disease and 50 controls were enrolled in the study. HLAalleles were analyzed using sequence-specific primer-polymerase chain reaction and nucleotide sequencing.Results: The HLA-B35 allele was significantly more common in patients with rheumatic heart disease than the control group (P =0.043). The HLA-B44 allele was significantly more common in control patients than in patients with rheumatic heart disease (P = 0.014).There was a significant inverse correlation between high-sensitivity C-reactive protein and mitral valve area (P = 0.001). There was nocorrelation between TNF-α levels and mitral valve area (P = 0.066).Conclusion: Our findings confirmed the association between HLA-B alleles and rheumatic heart disease.

🔖

Bu Makaleye Atıf Yap

BOYACI, B., ÜNLÜ, S., TUFAN, A., EYİOL, A., YAYLA, Ç., CEMRİ, M., YALÇIN, R. (2022). Relationship of serum HLA-B alleles and TNF-α with rheumatic heart disease. Turkish Journal of Medical Sciences, Cilt: 48 - Sayı: 4, 724–729. https://ajindex.com/articles/610269

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (11)

  1. Carapetis JR, McDonald M, Wilson NJ. Acute rheumatic fever. Lancet 2005; 366: 155-168.
  2. Rabuş M, Demirbağ R, Sezen Y, Taşar M, Taşkın A, Aksoy N, Kirali K, Yakut C. Serum prolidase activity in patients with degenerative and rheumatic heart valve diseases. Turk J Med Sci 2010; 40: 687-692.
  3. Guilherme L, Weidebach W, Kiss MH, Snitcowsky R, Kalil J. Association of human leukocyte class II antigens with rheumatic fever or rheumatic heart disease in a Brazilian population. Circulation 1991; 83: 1995-1998.
  4. Cassidy JT, Petty RE. Textbook of Pediatric Rheumatology. 2nd ed. Philadelphia, PA, USA: Churchill Livingstone; 1990. pp. 571-585. Goldsmith DP. Poststreptococcal rheumatic manifestations: an ongoing tale. J Clin Rheumatol 2010; 16: 1-2.
  5. Guedez Y, Kotby A, El-Demellawy M, Galal A, Thomson G, Zaher S, Kassem S, Kotb M. HLA class II associations with rheumatic heart disease are more evident and consistent among clinically homogeneous patients. Circulation 1999; 99: 2784-2790. Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC); European Association for Cardio-Thoracic Surgery (EACTS), Vahanian A, Alfieri O, Andreotti F, Antunes MJ, Barón-Esquivias G, Baumgartner H, Borger MA, Carrel TP et al. Guidelines on the management of valvular heart disease (version 2012). Eur Heart J 2012; 33: 2451-2496.
  6. Zoghbi WA, Enriquez-Sarano M, Foster E, Grayburn PA, Kraft CD, Levine RA, Nihoyannopoulos P, Otto CM, Quinones MA, Rakowski H et al. Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography. J Am Soc Echocardiogr 2003; 16: 777-802.
  7. Gibofsky A, Zabriskie JB. Rheumatic fever: new insights into an old disease. Bull Rheum Dis 1993; 42: 5-7. Bowness P. HLA B27 in health and disease: a double-edged sword? Rheumatology (Oxford) 2002; 41: 857-868.
  8. DiSciascio G, Taranta A. Rheumatic fever in children. Am Heart J 1980; 99: 635-658. Pickles W. Rheumatic fever. Lancet 1943; 2: 241-244.
  9. Toor D, Leal K, Kumar R, Sharma YP, Chakraborti A. Association of HLA-DRB1*14 with rheumatic heart disease patients from Chandigarh, North India. Biomarkers 2012; 17: 160-165.
  10. Ayoub EM, Barrett DJ, Maclaren NK, Krischer JP. Association of class II human histocompatibility leukocyte antigens with rheumatic fever. J Clin Invest 1986; 77: 2019-2026.
  11. Anastasiou-Nana MI, Anderson JL, Carlquist JF, Nanas JN. HLA-DR typing and lymphocyte subset evaluation in rheumatic heart disease: a s